Show/hide main menu

Research Groups

Biomarker Development Laboratory (BiD Lab)

Cellular behaviour

Cellular control networks direct the phenotypic behaviour of cells, responding to external cues such as hormones, Growth factors and nutrients to elicit appropriate reactions. Mapping these networks, understanding their connectivity and their sense of action, provides a basis upon which to model and predict cellular behaviour for example in the context of genetic variation, disease and drug treatment.

Therapeutic pathways

In cancer, somatic mutations are known to affect specific cellular controls, typically those that sit at key nodes within signalling hierarchies. These mutations confer cell autonomous growth, survival, genomic instability, etc, properties characteristic of transformed cells. Frequently observed mutations define candidate therapeutic targets/pathways and targeted drugs are already making an impact in the clinic.

Novel approaches

Monitoring the state of control networks in patient samples brings novel therapeutic candidates, pharmacodynamic readouts and a predictive framework in which to stratify patients and optimise the benefits of new targeted therapeutics. The inexorable move towards molecular insight based, patient stratification, is as yet poorly served by our ability to deliver the critical network status information in patient samples. In combination with the mapping of elements of the network, the newly established BiD laboratory is working on novel approaches to resolve this information gap.

Current projects

Development of Biomarker technologies and Biomarker exploitation for signal transduction pathways.

Key people

Contact details

For general enquiries, please contact: 

Dora Jonsdottir
Sitemap Site help Terms and conditions  Privacy policy  Accessibility  Modern slavery statement  Contact us

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454